Loading clinical trials...
Loading clinical trials...
What Works to Prevent Violence Against Women and Girls: Evaluation of the Communities Care Program in Somalia
The Communities Care (CC) program has demonstrated promise in changing harmful social norms associated with Gender-based violence (GBV) and increasing confidence in services for women and girls. Therefore, the study will adapt the existing CC program based on previous learnings with adults and expand programming to include adolescent boys and girls, creating the CC adult and CC adolescent program. The CC program intervention implementation will be led by Comitato Internazionale per lo Sviluppo dei Popoli (CISP) non-Governmental Organization (NGO) in partnership with Somalia Ministry of Education and local Women led Organizations (WLO), public schools and mapped GBV and child protection (CP) service providers in Banadir and Galmudug regions of Somalia. Johns Hopkins will collaborate with local research colleagues to evaluate the CC adult and CC adolescent program. The study will use a hybrid type 2 effectiveness-implementation design guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Quantitative methods will be used to measure outcomes at baseline and endline (24 months post baseline) with adults and adolescents (10 and older) participants in the CC programs in intervention compared to control districts in the two regions (Banadir and Galmudug) in South Central Somalia. Quantitative methods will also be used to measure outcomes with adults and adolescents (10 years and older) community members (members that do not participate in the CC program) in intervention and control districts in the 2 regions at baseline, midline (12-months), endline (24-months) and maintenance (36 months). In addition, quantitative and qualitative methods at midline and endline will be used to measure the CC adult and CC adolescent intervention reach, adoption, implementation and maintenance in intervention districts in the two regions.
What Works to Prevent Violence Against Women and Children (FCDO funded) has funded a collaboration between Johns Hopkins and Comitato Internazionale per lo Sviluppo dei Popoli (CISP) NGO in partnership with Somalia Ministry of Education and local researchers and Women led Organizations (WLO) to evaluate the Communities Care (CC) violence prevention intervention with both adults and adolescent in community and school-based settings in two regions of Somalia. The study will use a hybrid type 2 effectiveness-implementation design guided by the RE-AIM framework (e.g., reach, effectiveness, adoption, implementation and maintenance). Quantitative methods will be used to measure violence, health and social norms outcomes with adults (18 and older) and adolescents (10 and older) with participants in CC intervention districts and control districts in the two regions (Banadir and Galmudug) in South Central Somalia. Quantitative methods will also be used to measure outcomes with adults and adolescents (10 years and older) community members (members that do not participate in the CC program) in intervention and control districts in the 2 regions at baseline, midline (12-months), endline (24-months) and maintenance (36 months). In addition, quantitative and qualitative methods at midline and endline will be used to measure the CC adult and CC adolescent intervention reach, adoption, implementation and maintenance in intervention districts in the two regions.
Age
10 - 100 years
Sex
ALL
Healthy Volunteers
Yes
CISP Somalia
Mogadishu, Wadajir District, Somalia
Start Date
August 20, 2024
Primary Completion Date
October 31, 2028
Completion Date
November 1, 2029
Last Updated
February 13, 2026
3,500
ESTIMATED participants
Communities Care
BEHAVIORAL
Lead Sponsor
Johns Hopkins University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions